How many patients with schizophrenia do not respond to antipsychotic drugs?

被引：1
|
作者：
Samara, M. [1 ]
Nikolakopoulou, A. [2 ]
Salanti, G. [2 ]
Leucht, S. [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherapie, D-80290 Munich, Germany
[2] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
CONSENSUS;
D O I：
10.1016/S0924-977X(15)30717-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.069
引用
收藏
页码：S520 / S521
页数：2
相关论文
共 50 条
  • [41] Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders
    Rey, M. V.
    Molina, L.
    Recinos, B.
    Paz, B.
    Rovelo, M.
    Rodriguez Elias, F. E.
    Calderon, J.
    Arellano, A.
    Pomata, S.
    Perez-Lloret, S.
    MOVEMENT DISORDERS, 2016, 31 : S290 - S290
  • [42] Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs
    Hasnain, Mehrul
    Fredrickson, Sonja K.
    Vieweg, W. Victor R.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (06) : 715 - 721
  • [43] Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
    Khasawneh, Fadi T.
    Shankar, Gollapudi S.
    CARDIOLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [44] Switching from depot antipsychotic drugs to olanzapine in patients with chronic schizophrenia
    Godleski, LS
    Goldsmith, LJ
    Vieweg, WV
    Zettwoch, NC
    Stikovac, DM
    Lewis, SJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (02) : 119 - 122
  • [45] Changes in oxidative stress markers in patients with schizophrenia: The effect of antipsychotic drugs
    Tsai, Meng-Chang
    Liou, Chia-Wei
    Lin, Tsu-Kung
    Lin, I-Mei
    Huang, Tiao-Lai
    PSYCHIATRY RESEARCH, 2013, 209 (03) : 284 - 290
  • [46] May Non-antipsychotic Drugs Improve Cognition of Schizophrenia Patients?
    Buoli, M.
    Altamura, A. C.
    PHARMACOPSYCHIATRY, 2015, 48 (02) : 41 - 50
  • [47] Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia
    Lee, C
    Wu, KH
    Habil, H
    Dyachkova, Y
    Lee, P
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2006, 40 (05): : 437 - 445
  • [48] Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
    Bardenshtein, L. M.
    Mkrtumyan, A. M.
    Aleshkina, G. A.
    DIABETES MELLITUS, 2010, 13 (02): : 42 - 44
  • [49] Brain Networks Reveal the Effects of Antipsychotic Drugs on Schizophrenia Patients and Controls
    Towlson, Emma K.
    Vertes, Petra E.
    Muller-Sedgwick, Ulrich
    Ahnert, Sebastian E.
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [50] Influence of antipsychotic drugs on microRNA expression in schizophrenia patients - A systematic review
    Xavier, Gabriela
    Mauer, Jessica
    Ota, Vanessa K.
    Santoro, Marcos L.
    Belangero, Sintia I.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 176 : 163 - 172
12345